News
MCK
779.13
+2.05%
15.62
Weekly Report: what happened at MCK last week (0622-0626)?
Weekly Report · 3h ago
Financial Institutions Boost Dividends In June As 16 Companies Ready To Increase Payouts In July
Seeking Alpha · 1d ago
McKesson (MCK) Is Building An Automated Oklahoma Hub To Expand Drug Distribution
Simply Wall St · 3d ago
How High Can the Price of McKesson Stock (MCK) Rise? One Top Analyst Says a 35% Upside Is Possible
TipRanks · 4d ago
Press Release: McKesson Corporation Announces First Quarter Fiscal 2027 Earnings Release Date
Dow Jones · 5d ago
TCW Concentrated Large Cap Growth Fund Q1 2026 Portfolio Activity
Seeking Alpha · 5d ago
Cencora price target raised to $285 from $280 at BofA
TipRanks · 5d ago
Is Henry Schein Stock Underperforming the Nasdaq?
Barchart · 6d ago
MCK June 2027 Options Begin Trading
NASDAQ · 6d ago
Weekly Report: what happened at MCK last week (0615-0619)?
Weekly Report · 06/22 10:20
Charles Rhyee Reiterates Buy on McKesson, Keeps $1,012 Price Target on Steady Long-Term Earnings Outlook
TipRanks · 06/18 21:15
McKesson (MCK) Stock Could Be 17.3% Undervalued After Loan Deal And Buybacks
Simply Wall St · 06/17 15:31
If You Invested $100 In McKesson Stock 5 Years Ago, You Would Have This Much Today
Benzinga · 06/16 14:45
Weekly Report: what happened at MCK last week (0608-0612)?
Weekly Report · 06/15 10:21
McKesson Expands Capital Structure with New Term Loan
TipRanks · 06/12 12:30
IYK, MCK, CTVA, COR: ETF Outflow Alert
NASDAQ · 06/10 14:51
McKesson Price Target Cut to $925.00/Share From $1050.00 by Barclays
Dow Jones · 06/10 14:42
McKesson Is Maintained at Overweight by Barclays
Dow Jones · 06/10 14:42
Barclays Maintains Overweight on McKesson, Lowers Price Target to $925
Benzinga · 06/10 14:32
McKesson (MCK) Receives a Buy from Barclays
TipRanks · 06/10 09:17
More
Webull provides a variety of real-time MCK stock news. You can receive the latest news about McKesson through multiple platforms. This information may help you make smarter investment decisions.
About MCK
McKesson Corporation is a diversified healthcare services company, which focuses on advancing health outcomes for patients everywhere. Its U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products in the United States (U.S.). The Prescription Technology Solutions (RxTS) segment helps solve medication access, affordability and adherence challenges for patients by working across healthcare to connect patients, pharmacies, pharmacy benefit managers, health plans, and biopharma companies. The Medical-Surgical Solutions provides medical-surgical supply distribution, logistics, and other services to healthcare providers, including physician offices, hospital reference labs, and home healthcare agencies. The International segment provides distribution and services to wholesale, institutional, and retail customers in Canada and Norway. It also offers oncology and specialty solutions.